Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
While similar to tirzepatide, semaglutide targets only the GLP-1 receptor, which may provide different results for certain patients
Weight loss is part of the picture, not the whole picture
Kailera IPO'd in 2025 with HRS9531 (dual GLP-1/GIP, Phase 3 China readout ~17.7% weight loss February 2026) as its lead asset and HRS-4729 (the triple agonist) as an earlier-stage follow-on
Who Is Retatrutide Being Studied For
But not all shakes are created equal
The body therefore needs carnitine in order to function properly, particularly the muscles which need a constant supply of fuel
US$ 26.95
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
US$ 26.72
US$ 27.59
,type=downsize)
